Pattinson K T S
Nuffield Department of Anaesthetics, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK.
Br J Anaesth. 2008 Jun;100(6):747-58. doi: 10.1093/bja/aen094. Epub 2008 May 1.
Respiratory depression limits the use of opioid analgesia. Although well described clinically, the specific mechanisms of opioid action on respiratory control centres in the brain have, until recently, been less well understood. This article reviews the mechanisms of opioid-induced respiratory depression, from the cellular to the systems level, to highlight gaps in our current understanding, and to suggest avenues for further research. The ultimate aim of combating opioid-induced respiratory depression would benefit patients in pain and potentially reduce deaths from opioid overdose. By integrating recent findings from animal studies with those from human volunteer and clinical studies, further avenues for investigation are proposed, which may eventually lead to safer opioid analgesia.
呼吸抑制限制了阿片类镇痛药的使用。尽管在临床上已有充分描述,但直到最近,阿片类药物对大脑呼吸控制中枢的具体作用机制仍未得到很好的理解。本文从细胞水平到系统水平综述了阿片类药物引起呼吸抑制的机制,以突出我们目前理解上的差距,并提出进一步研究的途径。对抗阿片类药物引起的呼吸抑制的最终目标将使疼痛患者受益,并有可能减少阿片类药物过量导致的死亡。通过整合动物研究、人体志愿者研究和临床研究的最新发现,提出了进一步的研究途径,这最终可能带来更安全的阿片类镇痛。